Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)

NCT01146262 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

OTHER: cell therapy product
PROCEDURE: injection of the cell therapy product

Sponsor

Nantes University Hospital